US launch expected in mid-2019 – July 17, 2018 In a major positive for CeQur, the European insulin delivery start-up has acquired Calibra Finesse (One Touch Via) from J&J, the highly-anticipated three-day-wear, bolus-only (2-unit), 510(k)-cleared, super slim disposable insulin patch device. A US launch is expected in mid-2019 via [...]
Symetis spinout Polares Medical unlocked $25 million in venture capital financing to continue development of its mitral valve repair/replacement system and enter clinical testing. The Lausanne, Switzerland-based company’s device—a transcatheter, hemi-replacement system currently in the preclinical stages—aims to treat mitral regurgitation, caused by the leakage of blood backward through [...]
Company to open corporate headquarters in Minneapolis, MN Minneapolis, MN – June 26, 2018 – Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), announced today the completion of a $58 million equity financing. The round was led by Endeavour Vision and [...]
Milan – Italy, June 16, 2018: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today at the European Human Genetics Conference (ESHG 2018) that it has completed the acquisition of French-based tech company Interactive Biosoftware (IBS), the creators of Alamut®, the most used decision support software for clinical genomic [...]
Symetis grows and invests on its Ecublens site – article from AGEFI Symetis posted a 50% growth in 2017 and wants to strengthen its capabilities in Ecublens. La société de technologie médicale Symetis n’a cessé de se développer depuis son rachat par l’américain Boston Scientific il y a [...]
Vertiflex Announces Appointments to Board of Directors, Ray Baker, MD, and Richard Mott Company milestones demonstrate progress and commercial success of product portfolio CARLSBAD, Calif. – 8 June 2018 – Vertiflex, Inc., a leading innovator of advanced, minimally invasive interventions for spinal stenosis, today announced two new members [...]
CAESAREA, Israel, April 26, 2018 /PRNewswire/ — V-Wave Ltd., an Israel-based company that has developed a proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure (HF), announced today that it has closed a Series C financing of $70 million led by Deerfield Management [...]
Swiss medtech company Medartis is reportedly planning to expand into the U.S. market and continue investing in Germany with the funds from its recently-announced initial public offering. Medartis announced yesterday that its IPO could include up to 2.84 million new shares of common stock priced at 44 – 54 [...]
ZURICH, Feb 27 (Reuters) – Medartis Holding AG, a medical device maker specializing in surgical bone repairs, plans to sell shares in an initial public offering (IPO) on the SIX Swiss Exchange in the first half of 2018, it said on Tuesday. Medartis, whose products are sold in 44 [...]
The Myeloid Solution by SOPHiA GENETICS is the best-in-class molecular diagnostic application which empowers clinicians to more precisely diagnose hematological disorders Lausanne, SWITZERLAND – 06th February 2018: SOPHiA GENETICS, global leader in Data-Driven Medicine, unveiled today the world’s first capture-based myeloid clinical solution to receive the CE-IVD mark. The [...]